Derek N J Hart

Title: Innovations by Derek N J Hart

Introduction

Derek N J Hart is a notable inventor based in Brisbane, Australia. He has made significant contributions to the field of immunology through his innovative patents. With a total of two patents to his name, Hart's work focuses on advancing medical science and improving patient outcomes.

Latest Patents

Hart's latest patents include the Human CMRF-35-H9 receptor, which binds IgM. This isolated receptor has an amino acid sequence as set out in SEQ ID NO:1, or a derivative thereof that binds IgM. The receptor, along with peptides encoding its extracellular domain, has applications in methods of immunomodulation. This includes the blocking or inhibition of humoral immune responses in transplant patients. Another significant patent is for dendritic cell-specific antibodies. This patent describes an isolated antibody or preparation of antibodies comprising an antigen-binding domain, wherein the antigen is present on activated dendritic cells. Importantly, the antibody does not interact with CMRF-44 antigen or CD83 antigen.

Career Highlights

Derek N J Hart is associated with the Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland. His work at this institution has allowed him to focus on research and development in the field of immunology, contributing to advancements that have the potential to improve healthcare.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Derek N J Hart's innovative work in immunology, particularly through his patents, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact patient care and treatment methodologies.